Reticular GTM brain

Reticular offers reproductive genetic screening and embryo reports, with genetic counseling, to people planning pregnancies and pursuing IVF.

category

Reproductive genetics and embryo screening

market profile

  • text: Patients may seek genetic explanations after infertility or pregnancy loss, before or during IVF.
  • text: Existing PGT data can support additional embryo-level genetic analysis, although results must be interpreted with clinical professionals.

personas

  • title: Person experiencing infertility or recurrent pregnancy loss
    pains:
    • Seeking answers when prior testing has not explained losses.
    • Needs help understanding genetic findings and what they mean for conversations with a care team.
  • title: IVF intended parent
    pains:
    • Wants more context about existing embryos without another biopsy.
    • Must weigh costs and uncertain genetic predictions during an emotionally difficult process.
  • title: Reproductive endocrinologist or genetic counselor
    pains:
    • Needs clinically interpretable findings and clear limitations to discuss with patients.

icp

  • text: Individuals and couples trying to conceive or investigating infertility and pregnancy loss, including those not using IVF.
  • text: IVF patients with compatible existing PGT data and access to a care team for interpretation.

message pillars

  • text: Accessible at-home reproductive gene screening.
  • text: Professional support to interpret findings.
  • text: More context from existing embryo data.

objections

  • objection: Can this predict a healthy baby or diagnose the cause of loss?
    response: Results provide information for discussion with qualified clinicians, not a guaranteed outcome or standalone diagnosis.
  • objection: I am not using IVF.
    response: The partner screening panel uses an at-home cheek swab and does not require embryos.
  • objection: Genetic results are hard to interpret.
    response: The company includes a genetic counselor discussion and encourages care-team follow-up.

competitors

  • name: Orchid
    why: Embryo genetic screening for IVF patients.
  • name: Genomic Prediction
    why: Polygenic embryo screening for disease risk.
  • name: Nucleus Genomics
    why: Genomic and embryo analysis for intended parents.

influencers

  • name: John Yang
    url: https://reticular.com/blog/y-combinator-launch
    why: Founder explains the company's embryo screening approach.

keywords

  • recurrent pregnancy loss genetic testing
  • infertility genetic testing
  • embryo genetic screening
  • polygenic embryo screening
  • IVF genetic risk report
  • reproductive gene panel

voice

  • empathetic and patient-centered
  • plain-language and explanatory
  • carefully qualified

signals

  • text: A history of recurrent pregnancy loss or unexplained infertility may prompt a search for genetic answers.
  • text: Patients with compatible PGT data may be considering additional embryo analysis.

pricing

model: flat
starting price: $399 for one partner

motion

hybrid

channels

  • search
  • fertility publisher collaborations
  • referrals
  • paid creator collaborations
  • YC launch

confidence

high

Founders

  • name: John Yang
    title: Founder/CEO
    role: CEO
    bio: MIT AI + Mathematics '24. Published ML research in NeurIPS and Nature. Prior quant intern at Goldman Sachs. National achievements include USA Brain Bee Champion, USA Biology Olympiad Bronze Medalist, and First Place Euro Challenge Team Captain.

Back to YC companies